BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9557616)

  • 21. Blood-derived macrophage layers in the presence of hydrocortisone support myeloid progenitors in long-term cultures of CD34+ cord blood and bone marrow cells.
    Clausen J; Stockschläder M; Fehse N; Hassan HT; Gabl C; Zander AR
    Ann Hematol; 2000 Feb; 79(2):59-65. PubMed ID: 10741916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic myelogenous leukaemia CD34+ cells exit G0/G1 phases of cell cycle more rapidly than normal marrow CD34+ cells.
    Traycoff CM; Halstead B; Rice S; McMahel J; Srour EF; Cornetta K
    Br J Haematol; 1998 Aug; 102(3):759-67. PubMed ID: 9722304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
    Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin 6 receptor expression by human cord blood- or peripheral blood-derived primitive haematopoietic progenitors implies acquisition of different functional properties.
    Minamiguchi H; Yahata N; Kimura T; Fujiki H; Harada S; Wang J; Okuda K; Kaneko H; Hodohara K; Banba T; Yasukawa K; Ohyashiki JH; Ohyashiki K; Abe T; Sonoda Y
    Br J Haematol; 2000 Aug; 110(2):327-38. PubMed ID: 10971389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased migration of cord blood-derived CD34+ cells, as compared to bone marrow and mobilized peripheral blood CD34+ cells across uncoated or fibronectin-coated filters.
    Voermans C; Gerritsen WR; von dem Borne AE; van der Schoot CE
    Exp Hematol; 1999 Dec; 27(12):1806-14. PubMed ID: 10641598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different adhesive characteristics and VLA-4 expression of CD34(+) progenitors in G0/G1 versus S+G2/M phases of the cell cycle.
    Yamaguchi M; Ikebuchi K; Hirayama F; Sato N; Mogi Y; Ohkawara J; Yoshikawa Y; Sawada K; Koike T; Sekiguchi S
    Blood; 1998 Aug; 92(3):842-8. PubMed ID: 9680352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in cell cycle kinetics of candidate engrafting cells in human bone marrow and mobilized peripheral blood.
    Thornley I; Nayar R; Freedman MH; Stephens D; Crump M; Messner HA; Sutherland DR
    Exp Hematol; 2001 Apr; 29(4):525-33. PubMed ID: 11301193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efflux of CD34+ cells from bone marrow to peripheral blood is selective in steady-state hematopoiesis and during G-CSF administration.
    Steen R; Tjønnfjord GE; Gunnes Grøseth LA; Heldal D; Egeland T
    J Hematother; 1997 Dec; 6(6):563-73. PubMed ID: 9483191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proliferation and differentiation potential of CD133+ and CD34+ populations from the bone marrow and mobilized peripheral blood.
    Koutna I; Peterkova M; Simara P; Stejskal S; Tesarova L; Kozubek M
    Ann Hematol; 2011 Feb; 90(2):127-37. PubMed ID: 20821012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential.
    Traycoff CM; Abboud MR; Laver J; Clapp DW; Srour EF
    Exp Hematol; 1994 Dec; 22(13):1264-72. PubMed ID: 7525328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granulocyte colony-stimulating factor mobilized peripheral blood stem cells enter into G1 of the cell cycle and express higher levels of amphotropic retrovirus receptor mRNA.
    Horwitz ME; Malech HL; Anderson SM; Girard LJ; Bodine DM; Orlic D
    Exp Hematol; 1999 Jul; 27(7):1160-7. PubMed ID: 10390191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of marrow and blood haemopoietic progenitors in chronic lymphocytic leukaemia before and after chemotherapy.
    Sala R; Mauro FR; Bellucci R; De Propris MS; Cordone I; Lisci A; Foà R; de Fabritiis P
    Eur J Haematol; 1998 Jul; 61(1):14-20. PubMed ID: 9688287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homing-associated cell adhesion molecules and cell cycle status on the nucleated cells in the bone marrow, mobilized peripheral blood and cord blood.
    Lee YH; Lee YA; Noh KT; Kim KH; Han JY; Seo SY; Kwon HC; Kim JS; Kim HJ
    J Korean Med Sci; 2004 Aug; 19(4):523-8. PubMed ID: 15308842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
    Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
    Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency analysis of multidrug resistance-1 gene transfer into human primitive hematopoietic progenitor cells using the cobblestone area-forming cell assay and detection of vector-mediated P-glycoprotein expression by rhodamine-123.
    Fruehauf S; Breems DA; Knaän-Shanzer S; Brouwer KB; Haas R; Löwenberg B; Nooter K; Ploemacher RE; Valerio D; Boesen JJ
    Hum Gene Ther; 1996 Jun; 7(10):1219-31. PubMed ID: 8793546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice.
    Gothot A; van der Loo JC; Clapp DW; Srour EF
    Blood; 1998 Oct; 92(8):2641-9. PubMed ID: 9763545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the phenotype and clonogenicity of normal CD34+ cells from umbilical cord blood, granulocyte colony-stimulating factor-mobilized peripheral blood, and adult human bone marrow.
    Steen R; Tjønnfjord GE; Egeland T
    J Hematother; 1994; 3(4):253-62. PubMed ID: 7537606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flow cytometric characterization of CD34+ hematopoietic progenitor cells in mobilized peripheral blood and bone marrow of cancer patients.
    D'Arena G; Cascavilla N; Musto P; Greco M; Di Mauro L; Carella AM; Dello Iacono N; Carotenuto M
    Haematologica; 1996; 81(3):216-23. PubMed ID: 8767526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
    Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR
    Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.